{
  "nct_id": "NCT91863063",
  "indication": "Non-Small Cell Lung Cancer",
  "phase": "Phase 2",
  "sample_size": 239,
  "duration_weeks": 53,
  "dropout_rate": 0.23,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "Objective response rate"
  ],
  "secondary_endpoints": [
    "Progression-free survival",
    "Overall survival"
  ],
  "outcome_summary": "No significant difference compared to placebo",
  "success": 0,
  "failure_reason": "Drug-drug interactions affected efficacy",
  "start_date": "2024-01-25",
  "completion_date": "2025-01-30"
}